Dallas, TX
December 17, 2009, 08:00 EST
Dr. Joe Duarte's Market I.Q.


The Internet's Intelligence Digest
Intelligence, Market Timing, And Trading Strategy For Traders and Investors


Doctor Shortage Complicates Health Care's Future
What's Hot Today:
U.S. stock index futures were pointing to a lower open on Thursday. A rising dollar is getting the blame, but the deteriorating climate conference, and the health care uncertainty aren't exactly helping the overall investing environment.

Today's Economic Calendar:
  • Jobless Claims 8:30 AM ET

  • Leading Indicators 10:00 AM ET

  • Philadelphia Fed Survey 10:00 AM ET

  • EIA Natural Gas Report 10:30 AM ET

  • 3-Month Bill Announcement 11:00 AM ET

  • 6-Month Bill Announcement 11:00 AM ET

  • Fed Balance Sheet 4:30 PM ET

  • Money Supply 4:30 PM ET
News For Thought

Copenhagen climate conference left out in the cold. According to Reuters: "Prospects for a strong U.N. climate pact grew more remote on Thursday at the climax of two-year talks as ministers and leaders blamed leading emitters China and the United States for deadlock on carbon cuts." The report added that an impasse between the United States and China about emission cuts threatens to lead the conference to failure.

Wall Street Journal/NBC News poll confirms what others have been saying for weeks to months about Democrats. According to The Wall Street Journal: "Less than a year after Inauguration Day, support for the Democratic Party continues to slump, amid a difficult economy and a wave of public discontent, according to a new Wall Street Journal/NBC News poll." President Obama's job approval rating in the poll, which ended on 12-14-09 is 47%, just about in the same range as Rasmussen, Gallup, and others have registered recently. According to the report: "Democrats' problems seem in part linked to their ambitious health-care plan, billed as the signature achievement of Mr. Obama's first year. Now, for the first time, more people said they would prefer Congress did nothing on health care than who wanted to see the overhaul enacted."

Inside the poll, the news gets worse for the Democrats as "The biggest worry for Democrats is that the findings could set the stage for gains by Republican candidates in next year's elections. Support from independents for the president and his party continues to dwindle. In addition, voters intending to back Republicans expressed far more interest in the 2010 races than those planning to vote for Democrats, illustrating how disappointment on the left over attempts by party leaders to compromise on health care and other issues is damping enthusiasm among core party voters." Again, this poll is echoing results from Rasmussen polls over the last several months, proving the predictive power of the latter. Rasmussen's polling this past weekend registered new approval ratings lows for President Obama.

Republicans aren't exactly ringing the popularity bell either. According to the report: "Twenty-eight percent of voters expressed positive feelings about the GOP -- a number that has remained constant through the Democrats' decline over the summer and fall. Only 5% said their feelings toward the Republicans were "very positive."" Our conclusion is that the anti-incumbent sentiment is still rising, which means that a scenario where party representation may not change, but familiar faces disappear is just as likely as any other in 2010.

Two other important facts emerged in this poll. First, the president's personality is starting to fade as a positive. According to the report "Fifty percent now feel positive about him, six points lower than in October and an 18-point drop since his early weeks in office." Second, Speaker Pelosi, who announced that she is now in "campaign mode" may actually harm those candidates that she stumps for. According to the report: "Ms. Pelosi's presence on the campaign trail could do more harm than good. Fifty-two percent said they would be less likely to vote for a candidate who agreed with the speaker almost all the time, compared with 42% who felt that way about candidates siding with Republican leaders."

Doctor Shortage Complicates Health Care's Future
It's Much More Dangerous Than Anyone Knows
As health care "reform" stalls in Congress once again, the general public should consider that if and when the package passes, the compromises are ironed out, and the president finally signs the final bill into law, the system will move on to the next crisis, the lack of well trained physicians to take care of the surging number of patients that will supposedly have access to care.

To be sure, the lack of foresight and the potential for future consequences have never been the hallmark of political decisions. Yet, this one has the potential for some huge effects in the future, especially the political future of those who enact the "reform" package.

A little known fact is that in order to save money for Medicare, the funding for physician training programs was cut in 1997. That means that today's long waits at the doctor's office, and the projected shortage of physicians over the next 15 years was fueled, at least partially by the same government that is once again tinkering with the potential health of its constituents.

At the same time that training program funds were being cut, HMOs were empowered by the Clinton administration, adding layers of bureaucracy to the system, where physicians now have to ask for permission from the insurers to perform routine procedures on patients who actually need them. Most doctor's offices now have at least one person on their staff whose sole job is often just to ask for "approval" from insurers for what most in medicine consider routine interventions in patient care. In this scribe's office, part of the daily routine is talking to insurance companies about the use of "third tier" anti-inflammatory medication for patients. That means that a dedicated nurse has to explain to the clerk on the other end of the phone why the doctor wants to use Celebrex for a patient with arthritis. If the patient hasn't tried at least three other antiinflammatory medications before, the insurer won't pay for Celebrex. What makes this even more frustrating is that in the rare occasion when we get the approval, the patient can't afford the $50 or $60 copay that is required to get the medicine.

According to Bloomberg: "To combat a nationwide shortage of doctors, medical schools in the U.S. plan to add 3,000 first- year students by 2018. It won’t be enough." Why? According to the report: "The expansion, pushed for by the Association of American Medical Colleges, is being undercut by a U.S. health-care overhaul designed to supply medical insurance to an additional 31 million Americans and a cap on government-funded physician training programs that’s been frozen in place for 12 years, said Steven Safyer, of Montefiore Medical Center."

In fact, as Bloomberg reports: "Last year, there were 16,721 fewer primary-care doctors than needed in inner city and rural areas, according to the U.S. Health and Human Services Department. Residencies, the hospital based-training doctors undergo before they can practice medicine on their own, have been capped by Congress at about 90,000 since 1997 as a way to curb rising medical costs."

Consider this. According to Bloomberg: "Even with the push for more residencies, about 1,500 have gone unused for the last three years, the medical school group’s Salsberg said. This is because some hospitals find they no longer can provide supervision or hands-on experience necessary to educate all the residents they’ve been allocated, he said." Translation: there aren't enough physicians that are willing to go into academics to teach other physicians any more because the pay for the hard work involved in teaching physicians isn't worth the trouble.

What are the alternatives? Aside from waiting a long time to see someone when you're ill, your chances of seeing a non-physician "extender," such as a nurse practitioner or a physician's assistant are likely to rise. To be sure, that's not a knock on those professionals, who are often well trained, dedicated, and capable. But, at 4:00 A.M., when your abdominal aortic aneurysm is dissecting, and you're bleeding to death, you want to know that a capable vascular surgeon is available and willing to try and give you the best chance possible at that 50% survival rate under those conditions in the best of hands.

If the current trends remain in place, there won't be one of those capable folks available everywhere. And with the number of smokers, diabetics, and non-excersisers in the population, the number of vascular emergencies and cardiac related issues is certain to rise. And that's not all. What we see on a daily basis tells us that the chronic problems, such as osteoarthritis, spine problems, and other labor and resource intensive issues will also rise.

So what's the bottom line? There are too many people that need medical care. There aren't enough doctors to take care of all of them now. The medical education system is underfunded. The health insurers don't want to pay for any treatments that aren't bare bones, whether they work or not. And, even if the system was to change for the better overnight, it would still take years for the educational system to catch up to the needs of the population.

Conclusion

We're not trying to be negative here. We're just noticing that the longer this debate goes on, the more evidence to support slowing down and thinking about what we're doing rises. Yet, Congress and the president, looking for a political prize continue to push into a potential abyss.

The system, with all its warts, still takes good care of a lot of people. But the system is fraying, at all levels, especially that precious pipeline, future physicians. And if there is no one to take care of patients, what's the use of having "reform" and "access?"

That's why we're concerned about the "don't worry be happy" stuff emanating from Capitol Hill and the White House on this issue. In other words, the golden goose is sitting on a silver platter, the oven door is opening, and the welcoming fires are waiting.

Know when to sell and how to make money when the market falls. Get a detailed trading plan in your pocket. Read Dr. Duarte's All NEW Books "Market Timing For Dummies." and "Trading Futures For Dummies." The Trading Manuals for All Seasons. Also Available As Kindle Books.

 


Market Moves - Stock Of The Day
Oil Service HOLDRS Trust (NYSE: OIH) Stays Quiet
Energy stocks usually rally at this time of year. Yet, the Oil Service HOLDRS Trust (NYSE: OIH) is still well below its 52-week highs.



Chart Courtesy of StockCharts.com


Cold weather usually leads to a rally throughout the energy sector. Yet, this year's arctic blast has barely led to a bounce in the OIH. That suggests that economic expectations remain subdued.

Oil service stocks are usually in the midst of any energy rally. That's because these are the companies that keep the industry running. They build, manage, and often maintain and repair oil and natural gas rigs. But if demand for oil and gas are slow, due to a slower global economy, then oil service revenues and earnings are likely to suffer.

Oil prices have been cut more than 50% from their peak of 18 months ago, and don't seem to be boucing too aggressively, with the $70 area seeming to be the focal point at this time.

OIH is also well off its highs and delivering a feeble bounce, despite the potential for some mergers and acquisitions in energy rising.

What OIH is saying, barring some kind of sudden change, is that the safe bet right now is that oil prices, due to decreased demand, are likely to stay in the current price range for some time.

Technical Look at the Market
S & P Can't Seem To Break Out - SPY ETF Remains at 4-stars
The S & P 500 rallied slightly on 12-16, but again failed to close above 1119. This is still constructive action, especially since the volatility bands are still shrinking, a technical configuration that suggests a big move is coming.

Still, the suspense is bothersome, and the market is still torn between two major influences. That means that traders have to choose between the positive seasonality of the Christmas holidays, or the political uncertainties of the moment. That's a tough call, which is why the market is going nowhere.

So the technical aspects of the market are increasingly important, and that's why the shrinking volatility bands are very important to keep an eye on.

The bottom line is that it pays to be careful.

Summary of Start Rating System

We are adapting our star based rating system to the S & P SPDR ETF (NYSE: SPY). In this section a 5-star rating for SPY is a signal that down side risk is very low and that the chances of a further rise in prices are greater than those of a fall. A 4-star rating Means that the risk is less attractive but that the odds of a rise in SPY still outweigh the risks of a fall.

A 3-stars rating on SPY suggests that the odds of a rise and a fall are even. 2-stars and 1-stars suggest that down side risk is on the rise.

In no way is this star rating system intended as a series of buy and sell recommendations. The system is intended as a guide to the general trend of the market and the S & P SPDR ETF.

Star ratings can change rapidly based on the market's action. Followers of the ratings should review them on a daily basis.

Star Ratings for S & P SPDR ETF (NYSE: SPY) - updated 12-16-09

S & P SPDR ETF (NYSE: SPY), 4 stars on 12-1-09 - closing price 110.84. Closing price on 12-16-09 111.52. Short term support is at 109.57. Resistance is at 111.74 and is being tested. A sustained move move above 111.74 would raise the rating to 5-stars. A move below 109 would drop the rating to 3-stars.



Chart Courtesy of StockCharts.com




Chart Courtesy of StockCharts.com

 

 


Other Subscriber Reports are located on the website (log in required). These
reports are updated on a weekly basis (or as conditions require) and are not emailed:

S&P Timing  /  Bond Timing /  Dollar Timing /  Energy Timing
Gold Timing /  Tech Timing /  Biotech Timing


© Copyright 1996-2009, Market Timing Strategies, Inc., All Rights Reserved.
  • Market IQ reports may not be redistributed without permission.
  • Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.